论文信息 - Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC - 字舞流文

Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC

M. Kinoshita | S. Ono | H. Mochizuki | S. Tamakuma | S. Aosasa | H. Ohe | Y. Ohkusa | Yoshida Oda

[1] S. Ono,et al. [Clinico-experimental analysis of backgrounds of the severe surgical infections]. , 1991, Nihon Geka Gakkai zasshi.

[2] P. Braquet,et al. Platelet-activating factor and cytokine interactions in shock. , 1989, Resuscitation.

[3] T. Ogihara,et al. Direct evidence of elevated levels of circulating platelet-activating factor in a patient with disseminated intravascular coagulation syndrome. , 1989, Journal of lipid mediators.

[4] K. Katayama,et al. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood. , 1988, Journal of chromatography.

[5] Y. Imura,et al. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988. , 1986, Life sciences.

[6] Y. Imura,et al. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. , 1985, Biochemical pharmacology.

[7] H. Wechsler. "ENDOTOXIN SHOCK". , 1964, JAMA.